Difference between revisions of "Team:CKWA-China"

 
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
{{CKWA-China/header}}
 
{{CKWA-China/header}}
 
<html>
 
<html>
−
 
+
<style>
 +
.tp-leftarrow.tparrows.hermes, .tp-rightarrow.tparrows.hermes{
 +
  display: none;
 +
}
 +
</style>
 
<!--Main Slider-->
 
<!--Main Slider-->
 
         <section class="main-slider">
 
         <section class="main-slider">
Line 14: Line 18:
 
                             data-param4="" data-param5="" data-param6="" data-param7="" data-param8="" data-param9=""
 
                             data-param4="" data-param5="" data-param6="" data-param7="" data-param8="" data-param9=""
 
                             data-rotate="0" data-saveperformance="off" data-slotamount="default"
 
                             data-rotate="0" data-saveperformance="off" data-slotamount="default"
−
                             data-thumb="https://static.igem.org/mediawiki/2021/2/2f/T--CKWA-China--slide3.jpg" data-title="Slide Title"
+
                             data-thumb="" data-title="Slide Title"
 
                             data-transition="parallaxvertical">
 
                             data-transition="parallaxvertical">
  
Line 28: Line 32:
 
                                 data-y="['middle','middle','middle','middle']"
 
                                 data-y="['middle','middle','middle','middle']"
 
                                 data-frames='[{"from":"y:[100%];z:0;rX:0deg;rY:0;rZ:0;sX:1;sY:1;skX:0;skY:0;","mask":"x:0px;y:0px;s:inherit;e:inherit;","speed":1500,"to":"o:1;","delay":1000,"ease":"Power3.easeInOut"},{"delay":"wait","speed":1000,"to":"auto:auto;","mask":"x:0;y:0;s:inherit;e:inherit;","ease":"Power3.easeInOut"}]'>
 
                                 data-frames='[{"from":"y:[100%];z:0;rX:0deg;rY:0;rZ:0;sX:1;sY:1;skX:0;skY:0;","mask":"x:0px;y:0px;s:inherit;e:inherit;","speed":1500,"to":"o:1;","delay":1000,"ease":"Power3.easeInOut"},{"delay":"wait","speed":1000,"to":"auto:auto;","mask":"x:0;y:0;s:inherit;e:inherit;","ease":"Power3.easeInOut"}]'>
−
                                 <h4>LonEase</h4>
+
                                 <h4>LonEase--a Natural Protease</h4>
 
                             </div>
 
                             </div>
  
Line 38: Line 42:
 
                                 data-y="['middle','middle','middle','middle']"
 
                                 data-y="['middle','middle','middle','middle']"
 
                                 data-frames='[{"from":"y:[100%];z:0;rX:0deg;rY:0;rZ:0;sX:1;sY:1;skX:0;skY:0;","mask":"x:0px;y:0px;s:inherit;e:inherit;","speed":1500,"to":"o:1;","delay":1000,"ease":"Power3.easeInOut"},{"delay":"wait","speed":1000,"to":"auto:auto;","mask":"x:0;y:0;s:inherit;e:inherit;","ease":"Power3.easeInOut"}]'>
 
                                 data-frames='[{"from":"y:[100%];z:0;rX:0deg;rY:0;rZ:0;sX:1;sY:1;skX:0;skY:0;","mask":"x:0px;y:0px;s:inherit;e:inherit;","speed":1500,"to":"o:1;","delay":1000,"ease":"Power3.easeInOut"},{"delay":"wait","speed":1000,"to":"auto:auto;","mask":"x:0;y:0;s:inherit;e:inherit;","ease":"Power3.easeInOut"}]'>
−
                                 <h2>LonEase</h2>
+
                                 <h2>Suppress Cancer Recurrence </h2>
 
                             </div>
 
                             </div>
  
Line 48: Line 52:
 
                                 data-y="['middle','middle','middle','middle']"
 
                                 data-y="['middle','middle','middle','middle']"
 
                                 data-frames='[{"from":"y:[-100%];z:0;rX:0deg;rY:0;rZ:0;sX:1;sY:1;skX:0;skY:0;","mask":"x:0px;y:0px;s:inherit;e:inherit;","speed":1500,"to":"o:1;","delay":1000,"ease":"Power3.easeInOut"},{"delay":"wait","speed":1000,"to":"auto:auto;","mask":"x:0;y:0;s:inherit;e:inherit;","ease":"Power3.easeInOut"}]'>
 
                                 data-frames='[{"from":"y:[-100%];z:0;rX:0deg;rY:0;rZ:0;sX:1;sY:1;skX:0;skY:0;","mask":"x:0px;y:0px;s:inherit;e:inherit;","speed":1500,"to":"o:1;","delay":1000,"ease":"Power3.easeInOut"},{"delay":"wait","speed":1000,"to":"auto:auto;","mask":"x:0;y:0;s:inherit;e:inherit;","ease":"Power3.easeInOut"}]'>
−
                                 <div class="text">2021iGM ,CWKA-China is coming.</div>
+
                                 <div class="text">2021iGEM ,CWKA-China is coming.</div>
 
                             </div>
 
                             </div>
 
                         </li>
 
                         </li>

Latest revision as of 07:57, 21 October 2021

  • LonEase--a Natural Protease

    Suppress Cancer Recurrence

    2021iGEM ,CWKA-China is coming.
LonEase

LonEase

Recurrence of cancer after surgical treatment is a major problem facing mankind nowadays, and cancer recurrence is a great threat for cancer patients. For example, bladder cancer recurs in up to 24%-84% of patients 5 years after surgical resection, in which overexpression of C-MYC protein is associated with approximately 44%-69% of these cases. We have investigated that Lon protein from uropathogenic Escherichia coli (UPEC) can be effective enough to degrade C-MYC protein and thus inhibit the proliferation of cancer cells. We plan to produce highly active Lon protease from E. coli this year and use it to design a drug to improve the surgical prognosis of bladder cancer population with C-myc gene overexpression.

Our Video

Promotional Video

Email:schooloffice@cy.kaiwenacademy.cn

School Office:010-83028199